citalopram has been researched along with thromboplastin in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Diaz-Ricart, M; Escolar, G; Galan, AM; Lopez-Vilchez, I; White, JG | 1 |
Diaz-Ricart, M; Escolar, G; Galan, AM; Gasto, C; Lopez-Farre, A; Lopez-Vilchez, I; Navarro, V; Torramade, S; Zamorano-Leon, J | 1 |
2 other study(ies) available for citalopram and thromboplastin
Article | Year |
---|---|
Serotonin enhances platelet procoagulant properties and their activation induced during platelet tissue factor uptake.
Topics: Anticoagulants; Biological Transport; Blood Coagulation; Blood Platelets; Cell-Derived Microparticles; Citalopram; Flow Cytometry; Hirudins; Humans; Platelet Aggregation; Platelet Function Tests; Pseudopodia; Recombinant Proteins; Selective Serotonin Reuptake Inhibitors; Serotonin; Thrombin; Thromboplastin; Time Factors | 2009 |
Endothelial damage in major depression patients is modulated by SSRI treatment, as demonstrated by circulating biomarkers and an in vitro cell model.
Topics: Adult; Case-Control Studies; Citalopram; Depressive Disorder, Major; Endothelial Progenitor Cells; Endothelium, Vascular; Extracellular Matrix; Female; Human Umbilical Vein Endothelial Cells; Humans; In Vitro Techniques; Male; Middle Aged; Nitric Oxide Synthase Type III; Oxidative Stress; Platelet Activation; Reactive Oxygen Species; Selective Serotonin Reuptake Inhibitors; Thromboplastin; Thrombosis; Treatment Outcome; Vascular Cell Adhesion Molecule-1; von Willebrand Factor | 2016 |